- A multicentre, randomized, pharmacokinetic, endocrine and clinical study to evaluate formestane in breast cancer patients at first relapse: endocrine and clinical results. The Italian Trials in Medical Oncology (I.T.M.O.) group. Bajetta, E., Zilembo, N., Barni, S., Noberasco, C., Martinetti, A., Ferrari, L., Schieppati, G., Buzzoni, R., Jirillo, A., Amichetti, M., D'Aprile, M., Comella, G., Bichisao, E., Bolelli, G.F., Attili, A., Bombardieri, E. Ann. Oncol. (1997)